PharmaEngine Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,326	1,584	993.7	875.62	1,769	2,151
Short-Term Investments	3,649	3,133	2,867	2,752	1,837	1,663
Trading Asset Securities	-	-	-	-	55.59	-
Cash & Short-Term Investments	4,975	4,717	3,861	3,628	3,661	3,814
Cash Growth	-12.22%	22.17%	6.42%	-0.91%	-4.00%	12.37%
Accounts Receivable	181.89	262.44	1,844	174.17	160.34	160.48
Other Receivables	28.28	54.25	87.59	97.41	63.51	22.83
Receivables	210.17	316.69	1,932	271.58	223.85	183.31
Inventory	23.69	39.87	28.38	15.9	34.38	5.43
Prepaid Expenses	9.54	11.46	6.4	7.48	6.57	6.48
Other Current Assets	-	-	-	-	-	0.08
Total Current Assets	5,219	5,085	5,827	3,923	3,926	4,009
Property, Plant & Equipment	42.09	44.68	10.24	18.03	25.92	7.89
Other Intangible Assets	0.95	1.1	1.78	1.88	2.51	0.6
Long-Term Deferred Tax Assets	13.72	14.36	5.91	8	9.54	4.98
Other Long-Term Assets	2.53	2.53	2.44	2.98	2.5	3.9
Total Assets	5,278	5,148	5,848	3,954	3,967	4,026
Accounts Payable	-	35.58	-	-	-	-
Accrued Expenses	-	100.13	99.31	67.22	61.31	64.14
Current Portion of Leases	8.71	8.66	7.14	7.67	7.54	7.59
Current Income Taxes Payable	43.79	30.11	327.9	-	-	6.92
Other Current Liabilities	126.45	12.67	8.7	8.98	9.9	9.06
Total Current Liabilities	178.94	187.15	443.05	83.86	78.74	87.71
Long-Term Leases	31.25	33.46	-	7.14	14.81	-
Long-Term Deferred Tax Liabilities	4.61	0.99	4.96	-	0.92	-
Total Liabilities	214.8	221.59	448.01	91.01	94.47	87.71
Common Stock	1,457	1,457	1,457	1,457	1,457	1,466
Additional Paid-In Capital	1,616	1,616	1,616	1,616	1,617	1,620
Retained Earnings	2,124	1,987	2,461	925.31	937.85	1,101
Treasury Stock	-133.41	-133.41	-133.41	-133.41	-133.41	-248.24
Comprehensive Income & Other	-	-	-0.41	-1.79	-5.97	-
Shareholders' Equity	5,063	4,926	5,400	3,863	3,872	3,939
Total Liabilities & Equity	5,278	5,148	5,848	3,954	3,967	4,026
Total Debt	39.96	42.12	7.14	14.81	22.35	7.59
Net Cash (Debt)	4,935	4,675	3,854	3,613	3,639	3,806
Net Cash Growth	-12.81%	21.30%	6.65%	-0.71%	-4.39%	12.88%
Net Cash Per Share	34.35	32.48	26.78	25.14	25.32	26.30
Filing Date Shares Outstanding	143.68	143.68	143.68	143.68	143.69	143.6
Total Common Shares Outstanding	143.68	143.68	143.68	143.68	143.69	143.6
Working Capital	5,040	4,898	5,384	3,839	3,847	3,921
Book Value Per Share	35.24	34.28	37.58	26.89	26.95	27.43
Tangible Book Value	5,062	4,925	5,398	3,861	3,870	3,938
Tangible Book Value Per Share	35.23	34.28	37.57	26.87	26.93	27.42
Machinery	-	5.47	5.18	4.44	4.03	0.8
Leasehold Improvements	-	-	-	7.69	7.69	7.69